Public Profile

Roche Holding AG

Roche Holding AG, commonly referred to as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, producing unique products such as targeted therapies and advanced diagnostic tools. The company’s robust portfolio includes well-known medications like Herceptin and Avastin, which have transformed cancer treatment. Roche's dedication to innovation has earned it a prominent market position, consistently ranking among the top pharmaceutical companies globally. Its achievements in personalised healthcare and diagnostics underscore its role as a leader in advancing medical science and improving patient outcomes.

DitchCarbon Score

How does Roche Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Roche Holding AG's score of 82 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Roche Holding AG's reported carbon emissions

In 2023, Roche Holding AG reported total greenhouse gas emissions of approximately 6,000,000 kg CO2e across all scopes. This includes about 240,266,000 kg CO2e from Scope 1, 98,480,000 kg CO2e from Scope 2, and approximately 5,978,508,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 70% reduction in absolute Scope 1 and 2 emissions by 2029, based on 2022 levels. Additionally, Roche is committed to a 22.5% reduction in Scope 3 emissions from specific categories, including fuel- and energy-related activities and business travel, within the same timeframe. Roche has also pledged to achieve net-zero emissions across its entire value chain by 2045. This long-term commitment aligns with their near-term targets, which include a 90% reduction in Scope 1 and 2 emissions and a similar reduction in Scope 3 emissions by 2045, again using 2022 as the baseline year. These initiatives reflect Roche's dedication to sustainability and its proactive approach to addressing climate change within the pharmaceutical and biotechnology sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
249,350,000
000,000,000
000,000,000
Scope 2
114,452,000
00,000,000
00,000,000
Scope 3
6,402,719,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roche Holding AG's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Roche Holding AG is headquartered in CH, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roche Holding AG is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Novartis Pharmaceuticals Corporation

US
Chemicals nec
Updated 2 months ago
DitchCarbon Score

Joint Stock Company Pharmstandard

RU
Chemicals nec
Updated 2 days ago

Bayer

DE
Chemicals nec
Updated about 16 hours ago

Johnson And Johnson

US
Chemicals nec
Updated 1 day ago

Glaxosmithkline

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated about 3 hours ago

Bms

US
Chemicals nec
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers